The American Society of Clinical Oncology (ASCO) supports the elimination of tobacco products.
Toward that goal, ASCO urges the adoption of national policy that strengthens regulation of the sale, promotion, and distribution of such products.
To reduce cancer mortality, our regulatory policies must recognize that the nicotine within tobacco is an addictive substance, the use of which leads to 30% of all cancer deaths and a total of 419,000 deaths each year.
Restricting Advertising and Promotion : Tobacco-related advertising and promotion should be banned.
At a minimum, national policies should :
ban billboards ;
limit advertising to black and white text only ;
prohibit the sale or giveaway of products that contain tobacco brand names or logos ;
prohibit brand name sponsorship of sporting or entertainment events ;
and require stronger and more prominent warning labels on all tobacco products.
Restricting Access by Children and Teenagers : Despite existing state laws prohibiting sale of tobacco products to minors, children are able to buy such products easily.
National regulation of the sale and distribution of tobacco products is necessary to eliminate children's access to tobacco.
Where sales are permitted, they should be limited to face-to-face purchases by individuals 18 and older.
Vending machines and other means of distributing tobacco without a face-to-face purchase should be outlawed. (...)
Mots-clés Pascal : Tumeur maligne, Incidence, Prévention, Tabagisme, Education sanitaire, Publicité, Taxe, Exportation, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, Mortalité, Homme
Mots-clés Pascal anglais : Malignant tumor, Incidence, Prevention, Tobacco smoking, Health education, Advertising, Taxe, Export, United States, North America, America, Epidemiology, Mortality, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0319163
Code Inist : 002B04B. Création : 10/04/1997.